相关实验视频

Updated: Jan 18, 2026

A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations

A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations

Published on: December 1, 2017

对缺血性中风潜在的可药基因的系统探索,使用全基因组的门德尔随机化分析

Peng Zhang^1,2, Yulu He³, Qing Zhen¹

¹Department of Epidemiology and Biostatistics, School of Public Health, Jilin University, Changchun, China.

Brain and behavior

|September 9, 2025

概括

这项研究使用孟德尔随机化确定了与缺血性中风 (IS) 风险相关的六个可用药物的基因. 这些发现为IS治疗提供了潜在的治疗点.

科学领域:

遗传学和基因组学遗传学和基因组学
药物基因组学药物基因组学
神经科学是一个神经科学.

背景情况:

缺血性中风 (IS) 治疗存在持续的挑战.
确定新的治疗目标对于改善IS结果至关重要.
药物可用全基因组分析为目标发现提供了一个有前途的方法.

研究的目的:

系统地识别与缺血性中风 (IS) 相关的潜在可用药物的基因.
为了利用孟德尔随机化 (MR) 和多omics数据进行强大的基因发现.
探索已识别的基因的潜在副作用和功能作用.

主要方法:

进行了两样本的门德尔随机化 (MR) 分析,整合了可药物基因组,eQTL,pQTL和IS GWAS数据.
利用灵敏度和贝叶斯的局部化分析来证实因果关系.
进行了全现象MR和功能丰富分析 (Metascape),用于基因验证和探索.

主要成果:

确定了16个与IS相关的潜在可药物基因,其中3个在QTL数据集中具有显著性.
六个基因 (CALCRL,KCNJ11,NEK3,THSD1,MMP12,HSD17B12) 显示出强有力的协同定位的证据.
整个现象的MR表明CALCRL与乳腺瘤和HSD17B12与高血压的联系.

结论:

确定了六个关键的可药物基因 (CALCRL,KCNJ11,NEK3,THSD1,MMP12,HSD17B12),与缺血性中风 (IS) 风险有关.
这些基因代表了IS的潜在新型治疗点.
需要进一步研究这些基因在IS病原体中的特定作用.

关键词:

贝叶斯的局部化贝叶斯的局部化.门德尔的随机化这种基因是药物可变的基因.缺血性中风中风

更多相关视频

Mapping Alzheimer's Disease Variants to Their Target Genes Using Computational Analysis of Chromatin Configuration

Mapping Alzheimer's Disease Variants to Their Target Genes Using Computational Analysis of Chromatin Configuration

Published on: January 9, 2020

In Vivo Modeling of the Morbid Human Genome using Danio rerio

In Vivo Modeling of the Morbid Human Genome using Danio rerio

Published on: August 24, 2013

相关概念视频

Genome-wide Association Studies-GWAS

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...

Genetic Screens

Genetic Screens

Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which...